This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nishimura, M. Articles by Yoshimura, M. Search for Related Content PubMed PubMed Citation Articles by Nishimura, M. Articles by Yoshimura, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetic Eye Problems

Increased Serum Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy

Department of Clinical and Laboratory Medicine (M.N., M.U., A.N., K.O., M.Y.) and the First Department of Internal Medicine (K.N.), Kyoto Prefectural University of Medicine, Kyoto 602; and the Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University (H.T.), Osaka 570, Japan

Address all correspondence and requests for reprints to: Masato Nishimura, M.D., Department of Clinical and Laboratory Medicine, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto 602, Japan.

Human hepatocyte growth factor (hHGF) is a powerful inducer of angiogenesis. We investigated the relationship between serum hHGF concentrations and proliferative diabetic retinopathy, the major characteristic of which is retinal neovascularization. Serum hHGF concentrations were measured in diabetic (n = 135) and nondiabetic subjects (n = 80). The mean serum hHGF concentration in diabetic subjects without retinopathy was lower than that in nondiabetic subjects [0.041 ± 0.003 ng/mL (n = 62) vs. 0.080 ± 0.010 ng/mL (n = 80); P < 0.05], but was not different from that in diabetic subjects with background retinopathy (0.058 ± 0.007 ng/mL; n = 26) or preproliferative retinopathy (0.048 ± 0.010 ng/mL; n = 10). The mean serum hHGF concentration was increased in subjects with proliferative retinopathy who had not undergone photocoagulation (0.213 ± 0.025 ng/mL; n = 24), but not in those who had undergone photocoagulation (0.040 ± 0.008 ng/mL; n = 13). Circulating hHGF may be involved in the mechanism of neovascularization in the proliferative diabetic retinopathy, and measurement of serum hHGF may be helpful in predicting the presence of proliferative retinopathy in diabetic subjects.

This article has been cited by other articles:

				J.-W. Lin, W. H.-H. Sheu, W.-J. Lee, Y.-T. Chen, T.-J. Liu, C.-T. Ting, and W.-L. Lee Circulating Hepatocyte Growth Factor Level but Not Basic Fibroblast Growth Factor Level Is Elevated in Angiography-Proven Symptomatic Peripheral Artery Disease Angiology, September 1, 2007; 58(4): 420 - 428. [Abstract] [PDF]

				L. N. Bell, J. L. Ward, M. Degawa-Yamauchi, J. E. Bovenkerk, R. Jones, B. M. Cacucci, C. E. Gupta, C. Sheridan, K. Sheridan, S. S. Shankar, et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E843 - E848. [Abstract] [Full Text] [PDF]

				A. C. Clermont, M. Cahill, H. Salti, S. L. Rook, C. Rask-Madsen, L. Goddard, J. S. Wong, D. Bursell, S. E. Bursell, and L. P. Aiello Hepatocyte Growth Factor Induces Retinal Vascular Permeability via MAP-Kinase and PI-3 Kinase without Altering Retinal Hemodynamics. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2701 - 2708. [Abstract] [Full Text] [PDF]

				J.-T. Chen, T.-S. Lin, K.-C. Chow, H.-H. Huang, S.-H. Chiou, S.-F. Chiang, H.-C. Chen, T.-L. Chuang, T.-Y. Lin, and C.-Y. Chen Cigarette Smoking Induces Overexpression of Hepatocyte Growth Factor in Type II Pneumocytes and Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 264 - 273. [Abstract] [Full Text] [PDF]

				S. Machida, M. Tanaka, T. Ishii, K. Ohtaka, T. Takahashi, and Y. Tazawa Neuroprotective Effect of Hepatocyte Growth Factor against Photoreceptor Degeneration in Rats Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4174 - 4182. [Abstract] [Full Text] [PDF]

				J. Rehman, R. V. Considine, J. E. Bovenkerk, J. Li, C. A. Slavens, R. M. Jones, and K. L. March Obesity is associated with increased levels of circulating hepatocyte growth factor J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1408 - 1413. [Abstract] [Full Text] [PDF]

				H. Shibuki, N. Katai, S. Kuroiwa, T. Kurokawa, J. Arai, K. Matsumoto, T. Nakamura, and N. Yoshimura Expression and Neuroprotective Effect of Hepatocyte Growth Factor in Retinal Ischemia-Reperfusion Injury Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 528 - 536. [Abstract] [Full Text] [PDF]

				A. Cantón, R. Burgos, C. Hernández, C. Mateo, R. M Segura, J. Mesa, and R. Simó Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy Br. J. Ophthalmol., July 1, 2000; 84(7): 732 - 735. [Abstract] [Full Text]

				W. Cai, S. L. Rook, Z. Y. Jiang, N. Takahara, and L. P. Aiello Mechanisms of Hepatocyte Growth Factor-Induced Retinal Endothelial Cell Migration and Growth Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1885 - 1893. [Abstract] [Full Text]

				L L. Masmiquel, R. Burgos, C. Mateo, R. Martí, R. M Segura, and R. Simó Effect of panretinal photocoagulation on serum levels of laminin in patients with diabetes: a prospective study Br. J. Ophthalmol., September 1, 1999; 83(9): 1056 - 1059. [Abstract] [Full Text]

				Y. Yoshitomi, S. Kojima, T. Umemoto, K. Kubo, Y. Matsumoto, M. Yano, T. Sugi, and M. Kuramochi Serum Hepatocyte Growth Factor in Patients with Peripheral Arterial Occlusive Disease J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2425 - 2428. [Abstract] [Full Text]

				M. Nishimura, M. Ushiyama, K. Ohtsuka, M. Nishida, N. Inoue, A. Matsumuro, T. Mineo, and M. Yoshimura Serum Hepatocyte Growth Factor as a Possible Indicator of Vascular Lesions J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2475 - 2480. [Abstract] [Full Text]

				K. Shinoda, S. Ishida, S. Kawashima, T. Wakabayashi, T. Matsuzaki, M. Takayama, K. Shinmura, and M. Yamada Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus Br. J. Ophthalmol., July 1, 1999; 83(7): 834 - 837. [Abstract] [Full Text]

				M. Nishimura, T. Ikeda, M. Ushiyama, A. Nanbu, S. Kinoshita, and M. Yoshimura Increased Vitreous Concentrations of Human Hepatocyte Growth Factor in Proliferative Diabetic Retinopathy J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 659 - 662. [Abstract] [Full Text]